IMMUKIN

This brand name is authorized in Hong Kong, Malta, United Kingdom

Active ingredients

The drug IMMUKIN contains one active pharmaceutical ingredient (API):

1 Interferon gamma-1b UNII 21K6M2I7AG - INTERFERON GAMMA-1B

It is presumed that interferon gamma-1b increases macrophage cytotoxicity by enhancing the respiratory burst via generation of toxic oxygen metabolites capable of mediating the killing of intracellular micro-organisms. Read about Interferon gamma-1b

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
IMMUKIN Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AB03	Interferon gamma	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 43727
Country: HK	Department of Health Drug Office	Identifier(s): 43554
Country: MT	Medicines Authority	Identifier(s): AA565/39302, AA565/39304